Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by K Schalle
A Budget-Impact Analysis (BIA) of Immunizing Adults With Copd With the 13-Valent Vaccine (PCV13) Against Community- Acquired Pneumonia and Pneumococcal Disease
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
Public and Private Payer Perspectives on the Net Cost of Implementation of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Compared With 7-Valent Pneumococcal Conjugate Vaccine (PCV7) to in the United States
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Recommendations for the Prevention of Streptococcus Pneumoniae Infections in Infants and Children: Use of 13-Valent Pneumococcal Conjugate Vaccine (PCV13) and Pneumococcal Polysaccharide Vaccine (PPSV23)
Pediatrics
Child Health
Pediatrics
Perinatology
PIN64 Assessing the Cost-Effectiveness (CE) of Vaccinating the Elderly and At-Risk Adults With the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) Compared to the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) or No Vaccination (NoVac) in the UK
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Impact of the 7-Valent Pneumococcal Conjugate Vaccine on the Incidence of Childhood Pneumonia
Epidemiology and Infection
Epidemiology
Infectious Diseases
The Impact of 7-Valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease: A Literature Review
Advances in Therapy
Medicine
Pharmacology
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
MMWR. Morbidity and mortality weekly report
Health Information Management
Mutagenesis
Epidemiology
Health
Medicine
Toxicology
PIN54 Cost-Effectiveness of 2+1 Dosing of 13-Valent Pneumococcal Conjugate Vaccine Compared With 2+1 Dosing of 10-Valent Conjugate Vaccine in Preventing Pneumococcal Disease in Canada
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Effectiveness of the 13-Valent Pneumococcal Conjugate Vaccine Against Adult Pneumonia in Italy: A Case–control Study in a 2-Year Prospective Cohort
BMJ Open
Medicine
Effect of Use of 13-Valent Pneumococcal Conjugate Vaccine in Children on Invasive Pneumococcal Disease in Children and Adults in the USA: Analysis of Multisite, Population-Based Surveillance
The Lancet Infectious Diseases
Infectious Diseases
